BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1308 related articles for article (PubMed ID: 17122091)

  • 1. Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice.
    Luque RM; Huang ZH; Shah B; Mazzone T; Kineman RD
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E891-9. PubMed ID: 17122091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S; Peng XD; Frohman LA; Kineman RD
    Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
    Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
    J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in expression of the genes for the leptin receptor and the growth hormone-releasing peptide/ghrelin receptor in the hypothalamic arcuate nucleus with long-term manipulation of adiposity by dietary means.
    Kurose Y; Iqbal J; Rao A; Murata Y; Hasegawa Y; Terashima Y; Kojima M; Kangawa K; Clarke IJ
    J Neuroendocrinol; 2005 Jun; 17(6):331-40. PubMed ID: 15929739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone.
    Luque RM; Park S; Kineman RD
    Endocrinology; 2007 Jan; 148(1):300-9. PubMed ID: 17038558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats.
    Kappeler L; Zizzari P; Grouselle D; Epelbaum J; Bluet-Pajot MT
    J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
    Kamegai J; Unterman TG; Frohman LA; Kineman RD
    Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen replacement in vivo rescues the dysfunction of pituitary somatotropes in ovariectomised aromatase knockout mice.
    Yan M; Jones ME; Hernandez M; Liu D; Simpson ER; Chen C
    Neuroendocrinology; 2005; 81(3):158-66. PubMed ID: 16015026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW; Root MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic changes in peripheral growth hormone levels do not affect ghrelin stomach mRNA expression and serum ghrelin levels in three transgenic mouse models.
    Nass R; Liu J; Hellmann P; Coschigano KT; Gaylinn B; Berryman DE; Kopchick JJ; Thorner MO
    J Neuroendocrinol; 2004 Aug; 16(8):669-75. PubMed ID: 15271059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ghrelin administration on decreased growth hormone status in obese animals.
    Iwakura H; Akamizu T; Ariyasu H; Irako T; Hosoda K; Nakao K; Kangawa K
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E819-25. PubMed ID: 17595213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function.
    Luque RM; Kineman RD
    Endocrinology; 2006 Jun; 147(6):2754-63. PubMed ID: 16513828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
    De Gennaro Colonna V; Zoli M; Settembrini BP; Ciceri S; De Marco A; Cella SG; Agnati LF; Muller EE
    J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways.
    Luque RM; Gahete MD; Hochgeschwender U; Kineman RD
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E395-403. PubMed ID: 16825606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-associated differences in the leptin and ghrelin systems related with the induction of hyperphagia under high-fat diet exposure in rats.
    Priego T; Sánchez J; Picó C; Palou A
    Horm Behav; 2009 Jan; 55(1):33-40. PubMed ID: 18718472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.
    Bédard K; Strecko J; Thériault K; Bédard J; Veyrat-Durebex C; Gaudreau P
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the pituitary growth hormone-releasing hormone receptor in ageing male and female LOU rats: new insights into healthy ageing.
    Veyrat-Durebex C; Alliot J; Gaudreau P
    J Neuroendocrinol; 2005 Nov; 17(11):691-700. PubMed ID: 16218997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.